Teleflex Incorporated Reports Study Results Of ARROWg+ard® Technology Effectiveness In Preventing Infections And Associated Costs In An Infection-Prone Insertion Site

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced that newly published research has reaffirmed the ability of catheters protected with ARROWg+ard® Technology to reduce both bloodstream infections and direct costs associated with treating those infections.1

Help employers find you! Check out all the jobs and post your resume.